Pilot Study of a Pharmacy Intervention for Older Adults With Cancer
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Breast Cancer, Lung Cancer, Cancer, Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 65 - Any |
| Updated: | 3/6/2019 |
| Start Date: | January 2017 |
| End Date: | September 2021 |
The purpose of this research study is to address the challenge of medication management for
older patients undergoing treatment for cancer. The sponsor of this protocol is the
Massachusetts General Hospital Cancer Center who is providing funding for this research
study.
older patients undergoing treatment for cancer. The sponsor of this protocol is the
Massachusetts General Hospital Cancer Center who is providing funding for this research
study.
The goals of the proposed study are: (1) to demonstrate the feasibility and acceptability of
delivering PRIME (Pharmacist Reconciliation to Improve Medication Management in the Elderly)
to older patients with breast, gastrointestinal, and lung cancers; and (2) to estimate the
effect size (i.e. the magnitude of the difference between groups) of PRIME for improving
medication management (e.g. accurate medication list, less polypharmacy, fewer potentially
inappropriate medications) and achieving up-to-date vaccinations.
delivering PRIME (Pharmacist Reconciliation to Improve Medication Management in the Elderly)
to older patients with breast, gastrointestinal, and lung cancers; and (2) to estimate the
effect size (i.e. the magnitude of the difference between groups) of PRIME for improving
medication management (e.g. accurate medication list, less polypharmacy, fewer potentially
inappropriate medications) and achieving up-to-date vaccinations.
Inclusion Criteria:
- Age 65 or older
- Diagnosed with any stage breast, GI or lung cancer
- Panning to receive first-line chemotherapy at MGH
- Verbal fluency in English
Exclusion Criteria:
- Unwilling or unable to participate in the study
- Significant psychiatric, cognitive or other comorbid disease which the treating
clinician believes prohibits informed consent or participation in the study
We found this trial at
1
site
Click here to add this to my saved trials
